Award recordCONTRACT

ADVANCED ACCELERATOR APPLICATIONS USA INC

PIID 36C25524N0203· VHA· 255-NETWORK CONTRACT OFFICE 15 (36C255)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $429,198 net obligations· UEI JNM4NBNHFE66· NY

Description

PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)

First action · last action
2024-04-04 · 2025-10-21
Transactions
2
First transaction's obligation
$746,610
Base + all options value (sum of deltas)
$429,198
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25524A0025
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$746,610$0Base award · 2024-04-04 · this action $746,610 · running total $746,610Modification P00002 · 2025-10-21 · this action -$317,412 · running total $429,198
  • Base2024-04-04+$746,610= $746,610
  • Mod P000022025-10-21-$317,412= $429,198
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-04-04+$746,610$746,610PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)
Mod P00002· OTHER ADMINISTRATIVE ACTION2025-10-21−$317,412$429,198PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JNM4NBNHFE66)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0132255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$1,200,000FY2026
36C26026N0121260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$996,874FY2026
36C24926N0263249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$823,062FY2026
36C25525N0282255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$166,146FY2025
36C25525N0176255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS$1,362,395FY2025
36C25225F0044252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$631,354FY2025

Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25526N0376RED RIVER PHARMACY OF JONESBORO, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$233,435FY2026
36C25526N0394NOVARTIS PHARMACEUTICALS CORPORATION255-NETWORK CONTRACT OFFICE 15 (36C255)$891,651FY2026
36C25526N0392SOFIE CO.255-NETWORK CONTRACT OFFICE 15 (36C255)$357,066FY2026
36C25526N0361CARDINAL HEALTH 414, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$228,679FY2026
36C25526D0057CARDINAL HEALTH 414, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25524N0203_3600_36C25524A0025_3600 · retrieved 2026-09-26.